We are proud to announce that James Park, CEO of LOTTE BIOLOGICS, will be presenting at the 43rd J.P. Morgan Healthcare Conference on January 16th at 1:15 PM PST. During his presentation, he will share insights into our strategic vision and future plans for the biopharma and CDMO industries.

The J.P. Morgan Healthcare Conference is a significant platform where industry leaders gather to shape the future of healthcare and biotechnology. We are excited to be part of this dynamic discussion and to showcase how LOTTE BIOLOGICS is contributing to growth in the CDMO space. 

We look forward to connecting with industry peers and fostering impactful collaborations. See you there!